HLA-DRB1 and myeloid sarcoma: Compared with HLA-DRB1*15:01 negative individuals with a sleep duration of more than 7 hours/night, the adjusted OR of MS was 6.01 (95% CI: 3.26 to 11.10) among HLA-DRB1*15:01 carriers with short habitual sleep duration.